Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
CD47-GEZIELTE THERAPIEN ZUR BEHANDLUNG VON INFEKTIONSKRANKHEITEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2014748994
EP Publication Number
2953633
E-Number
933375
Language
EN
PCT Number
US14014905
Publication Date
16.12.2015 A
04.10.2017 B1
Registration Date
04.10.2017
AT Publication Date
15.10.2017
Application Date
05.02.2014
Registration Number
-
Priorities
05.02.2013
US
201361761133 P
IPC
A61K 35/00 20060101AFI20160808BHEP
Maximum Duration of Protection
05.02.2034
Owner
The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US
The United States of America, as represented by The Secretary, Department of Health and Human Services6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, Maryland 20892-7660US
The Regents of the University of California1111 Franklin Street, 12th Floor Oakland, CA 94607-5200US
Representative
No representatives present
Inventor
WEISKOPF, Kipp745 Menlo Avenue Unit 10 Menlo Park, California 94025US
HASENKRUG, Kim J.1990 Red Crow Road Victor Montana 59875US
STODDART, Cheryl.A.360 Esplanade Avenue, Apt. 10 Pacifica, California 94044US
MCCUNE, Joseph M.904 Steiner St. San Francisco, California 94117US
WEISSMAN, Irving L.747 Santa Ynez Street Stanford, California 94305US